Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry

被引：39

作者：

Corbett, DF

Heightman, TD

Moss, SF

Bromidge, SM

Coggon, SA

Longley, MJ

Roa, AM

Williams, JA

Thomas, DR

机构：

[1] GlaxoSmithKline Inc, Discovery Res, High Throughput Chem, Harlow CM19 5AW, Essex, England

[2] GlaxoSmithKline Inc, Neurol & GI Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England

[3] GlaxoSmithKline Inc, Psychiat Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England

[4] Glaxo SmithKline Pharmaceut, Screening Sci Dept, Ctr Invest Basica, Madrid 28760, Spain

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 18期

关键词：

5-ht(5A) receptor; 5-ht(5A) antagonist; high-throughput chemistry; solid-phase synthesis;

D O I：

10.1016/j.bmcl.2005.06.024

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

High-throughput screening of an array of biphenylmethylamines synthesised by high-throughput solid-phase chemistry resulted in the identification of compounds with high-affinity for the 5-ht(5A) receptor. The structure-activity relationship within this series and further array synthesis led to the identification of the biphenylmethylamine derivative 11, a potent and selective 5-ht(5A) receptor antagonist. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：4014 / 4018

页数：5

共 50 条

[21] Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia
Yamazaki, Mayako
Yamamoto, Noriyuki
Yarimizu, Junko
Okabe, Mayuko
Moriyama, Ai
Furutani, Masako
Marcus, Monica M.
Svensson, Torgny H.
Harada, Katsuya
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (05) : 620 - 629
[22] Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold
Deng, Xinxian
Guo, Lin
Xu, Lili
Zhen, Xuechu
Yu, Kunqian
Zhao, Weili
Fu, Wei
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (18) : 3970 - 3974
[23] Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor
Thomas, DR
Larminie, CG
Lyons, HR
Fosberry, A
Hill, MJ
Hayes, PD
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 91 - 99
[24] Distribution of 5-HT2C and 5-ht5a receptor mRNA in human brain
Pasqualetti, M
Ori, M
Marazziti, D
Castagna, M
Nardi, I
ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 245 - 245
[25] THE 5-HT2C/2B RECEPTOR ANTAGONIST SB-200646A IS A POTENT AND SELECTIVE ANTAGONIST OF THE HUMAN 5-HT2C RECEPTOR
WOOD, MD
GAGER, TL
THOMAS, DR
NEWTON, RA
PHIPPS, SL
ELLIOTT, JM
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P155 - P155
[26] Developmental expression of 5-HT5A receptor mRNA in the rat brain
García-Alcocer, G
Sarabia-Altamirano, G
Martínez-Torres, A
Miledi, R
NEUROSCIENCE LETTERS, 2005, 379 (02) : 101 - 105
[27] Distribution of the 5-HT5A serotonin receptor mRNA in the human brain
Pasqualetti, M
Ori, M
Nardi, I
Castagna, M
Cassano, GB
Marazziti, D
MOLECULAR BRAIN RESEARCH, 1998, 56 (1-2): : 1 - 8
[28] KETANSERIN - A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST
KOCH, H
PHARMACY INTERNATIONAL, 1982, 3 (08): : 244 - 245
[29] SB-616234-A -: a novel, potent and selective 5-HT1B receptor antagonist
Watson, J
Scott, C
Langmead, CJ
Wyman, P
Smith, PW
Dawson, LA
Price, GW
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S385 - S385
[30] Sustainable Synthesis of a Potent and Selective 5-HT7 Receptor Antagonist Using a Mechanochemical Approach
Canale, Vittorio
Frisi, Valeria
Bantreil, Xavier
Lamaty, Frederic
Zajdel, Pawel
JOURNAL OF ORGANIC CHEMISTRY, 2020, 85 (16): : 10958 - 10965

← 1 2 3 4 5 →